Evidence map›Paper›PMID 30276955›Full record

ArticleAging cell2018

Replacement of microglia in the aged brain reverses cognitive, synaptic, and neuronal deficits in mice.

Monica R P Elmore, Lindsay A Hohsfield, Enikö A Kramár, Lilach Soreq, Rafael J Lee, Stephanie T Pham, Allison R Najafi, Elizabeth E Spangenberg, Marcelo A Wood, Brian L West and 1 more

Open access · goldAbstract read
In one paragraph

Article in Aging cell, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 200 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
200citing papers in PubMed, 1 pooled it
15.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

200 citing papers in PubMed, 1 synthesis or guideline pooled it, 385 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

140 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Monica R P ElmoreDepartment of Neurobiology and Behavior, University of California, Irvine, California.
Lindsay A HohsfieldDepartment of Neurobiology and Behavior, University of California, Irvine, California.
Enikö A KramárDepartment of Neurobiology and Behavior, University of California, Irvine, California.
Lilach SoreqUniversity College London, London, UK.
Rafael J LeeDepartment of Neurobiology and Behavior, University of California, Irvine, California.
Stephanie T PhamDepartment of Neurobiology and Behavior, University of California, Irvine, California.
Allison R NajafiDepartment of Neurobiology and Behavior, University of California, Irvine, California.
Elizabeth E SpangenbergDepartment of Neurobiology and Behavior, University of California, Irvine, California.
Marcelo A WoodDepartment of Neurobiology and Behavior, University of California, Irvine, California.
Brian L WestPlexxikon Inc, Berkeley, California.
Kim N GreenDepartment of Neurobiology and Behavior, University of California, Irvine, California.
University of California, Irvine · USPlexxikon (United States)University College London · GB

Funding

UC Irvine Alzheimer's Disease Research Center Induced Pluripotent Stem Cell CoreP50AG016573 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI LAFERLA, FRANK M · 2000 to 2019
$37.0M
Origins, properties, and therapeutic potential of cells that repopulate the microglia-depleted adult brainR01NS083801 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI Kim Green · 2014 to 2026
$5.6M
Microglia are necessary for cortical plaque formation in Alzheimer's diseaseRF1AG056768 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI GREEN, KIM · 2018 to 2018
$2.7M
Alzheimer's Association AARF-16-442762Alzheimer's Society UK 172065NIA NIH HHS P50 AG016573NIA NIH HHS RF1 AG056768NINDS NIH HHS R01 NS083801
6 · The paper itself

Abstract

Microglia, the resident immune cell of the brain, can be eliminated via pharmacological inhibition of the colony-stimulating factor 1 receptor (CSF1R). Withdrawal of CSF1R inhibition then stimulates microglial repopulation, effectively replacing the microglial compartment. In the aged brain, microglia take on a "primed" phenotype and studies indicate that this coincides with age-related cognitive decline. Here, we investigated the effects of replacing the aged microglial compartment with new microglia using CSF1R inhibitor-induced microglial repopulation. With 28 days of repopulation, replacement of resident microglia in aged mice (24 months) improved spatial memory and restored physical microglial tissue characteristics (cell densities and morphologies) to those found in young adult animals (4 months). However, inflammation-related gene expression was not broadly altered with repopulation nor the response to immune challenges. Instead, microglial repopulation resulted in a reversal of age-related changes in neuronal gene expression, including expression of genes associated with actin cytoskeleton remodeling and synaptogenesis. Age-related changes in hippocampal neuronal complexity were reversed with both microglial elimination and repopulation, while microglial elimination increased both neurogenesis and dendritic spine densities. These changes were accompanied by a full rescue of age-induced deficits in long-term potentiation with microglial repopulation. Thus, several key aspects of the aged brain can be reversed by acute noninvasive replacement of microglia.

Indexed as

AgingAnimalsCell CountCell ShapeCognitionCytoskeletonDendritic SpinesGene Expression RegulationInflammationLipopolysaccharidesLong-Term PotentiationMaleMice, Inbred C57BLMicrogliaNeurogenesisNeuronsCsf1r protein, mouseLipopolysaccharidesReceptors, Granulocyte-Macrophage Colony-Stimulating Factoragingcolony-stimulating factor 1 receptorlong-term potentiationmicrogliaplx5622repopulation

Identifiers

PMID30276955
PMCPMC6260908
OpenAlexW2894787694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.